Besides, researchers demonstrated that long-term melatonin treatment mitigates diabetic cardiomyopathy and reduces myocardial susceptibility to I/R insult through preserving mitochondrial quality control via SIRT6-AMPK-PGC1α-AKT signaling pathway (Yu et al., 2021). This evidence concerns the gene SIRT6 and diabetic cardiomyopathy.